The Lantz Family
#carolinestrong
Nov 2017: Diagnosed with Stage IV high-risk Neuroblastoma. Nov 2017–Apr 2019: Completed standard treatment; NED. Apr 2019–Apr 2021: Completed DFMO clinical trial. Apr 2022: Relapse. Apr 2022–Jun 2023: Completed relapse treatment; NED again. Jun 2023–Jun 2024: High-dose DFMO (compassionate use) clinical trial. Jun 2024: Second relapse. Jul 2025: NED again. Mar 2026: Relapse.
On this exact day - Black Friday, November 24, 2017, Caroline was diagnosed with Stage IV, High-Risk Neuroblastoma. 6 years later, November 24, 2023, another Black Friday, we took a drive down to the hospital for the annual "Snowman picture."

Caroline was discharged from Vanderbilt on Saturday and is now home resting. Other than the "normal" nausea and belly pain, the week was relatively uneventful. She will get daily Leukine shots for the next week to help bring up her neutrophils (immune system). We're hoping she recovers well at home, and is able to enjoy the next two weeks of "track out break" from school.
This coming Saturday (3/25), Caroline will be speaking as an ambassador for the hospital at the "Clip !n 4 the Cure" event, which raises funds for cancer research to find cures. If you’d like to support the event by participating or donating to the cause, click here for the link.